Specific Photothermal Ablation Therapy of Endometriosis by Targeting Delivery of Gold Nanospheres
TNYL-conjugated gold nanospheres specifically target EphB4 receptors in endometriosis lesions, enabling photothermal ablation therapy that inhibits lesion growth and reduces inflammation and hormonal imbalance without toxicity.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (39)
- Antiangiogenesis Therapy for Endometriosis via openalex
- Challenges in the development of novel therapeutic strategies for treatment of endometriosis via openalex
- Emerging treatment of endometriosis via openalex
- Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis via openalex
- Letrozole and Curcumin Loaded-PLGA Nanoparticles: A Therapeutic Strategy for Endometriosis via openalex
- Novel targets for the treatment of endometriosis via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- W2016977479 via openalex
- W2018304270 via openalex
- W2021117616 via openalex
- W2033559612 via openalex
- W2038394965 via openalex
- W2057426055 via openalex
- W2058366845 via openalex
- W2062322931 via openalex
- W2076257412 via openalex
- W2078947800 via openalex
- W2084567900 via openalex
- W2108615682 via openalex
- W2135160315 via openalex
- W2135420031 via openalex
- W2145656793 via openalex
- W2148836005 via openalex
- W2148924929 via openalex
- W2154321074 via openalex
- W2166828161 via openalex
- W4211081176 via openalex
- W1118075330 via openalex
- W4252081711 via openalex
- W1584018958 via openalex
- W1903778810 via openalex
- W1968001867 via openalex
- W1985962805 via openalex
- W1987263161 via openalex
- W1999364829 via openalex
- W2002854478 via openalex
- W2010198991 via openalex
Cited by (17)
- Lesion-centric reprogramming: hydrogel-enabled photothermal reset of endometriosis pain 2026
- Neutrophil hitchhiking liposomal drugs for starvation therapy in endometriosis 2025
- Highly Stable and Bright NIR‐II AIE Dots for Fluorescence Imaging‐Guided Photothermal Ablation of Endometriosis 2025
- Research on the Application of Nanoimaging Technology in the Diagnosis of Endometriosis 2025
- A Multifunctional Molecular Probe for Multimodal Imaging-Guided Potent Photothermal/Photodynamic Therapy of Endometriosis 2025
- Emerging Trends in Nanotechnology for Endometriosis: Diagnosis to Therapy 2024
- Treatment of endometriosis with mifepristone mediated by nanostructured lipid carriers 2024
- Emerging bioengineering breakthroughs in precision diagnosis and therapy for endometriosis and adenomyosis 2024
- Emerging strategies for the treatment of endometriosis 2024
- Additional file 1 of Highly specific neutrophil-mediated delivery of albumin nanoparticles to ectopic lesion for endometriosis therapy 2024
- Imaging of Endometriotic Lesions Using cRGD-MN Probe in a Mouse Model of Endometriosis 2024
- Additional file 1 of Highly specific neutrophil-mediated delivery of albumin nanoparticles to ectopic lesion for endometriosis therapy 2024
- Highly specific neutrophil-mediated delivery of albumin nanoparticles to ectopic lesion for endometriosis therapy 2023
- Applications of nanomaterials in endometriosis treatment 2023
- Nanotechnologies for the detection and treatment of endometriosis 2023
- Effect of PLGA Nanoparticle-Mediated Delivery of miRNA 503 on The Apoptosis of Ovarian Endometriosis Cells. 2022
- Homing Peptide-Based Targeting of Tenascin-C and Fibronectin in Endometriosis 2021
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:20:37.704673+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00